ING5 and ovarian cancer: In ovarian cancer cells, miR-200b/200a/429 targets ING5 which blocks miR-200b/200a/429-induced malignant transformation (Guan et al., 2020), and miR-1307 targets and down-regulated ING5 expression (Chen et al., 2017).